William A Christmas, DO in Arcadia, MO - Emergency Medicine

William A Christmas, DO is a Emergency Medicine physician based in Arcadia, Missouri. William A Christmas is licensed to practice in Missouri (license number 117991) and his current practice location is 505 Thompson Ln, Arcadia, Missouri. He can be reached at his office (for appointments etc.) via phone at (573) 366-3284.

NPI number for William A Christmas is 1659324457 and his current mailing address is 505 Thompson Ln, Arcadia, Missouri. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1659324457.

Contact Information

	William A Christmas, DO
	505 Thompson Ln, Arcadia, MO 63621-9153
	(573) 366-3284
	Not Available

Physician's Profile

Full Name	William A Christmas
Gender	Male
Speciality	Emergency Medicine
Location	505 Thompson Ln, Arcadia, Missouri
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1659324457
Provider Enumeration Date: 05/19/2006
Last Update Date: 07/10/2014

Medical Identifiers

Medical identifiers for William A Christmas such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1659324457	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	117991 (Missouri)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. William A Christmas is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
William A Christmas, DO 505 Thompson Ln, Arcadia, MO 63621-9153 Ph: (573) 366-3284	William A Christmas, DO 505 Thompson Ln, Arcadia, MO 63621-9153 Ph: (573) 366-3284

News Archive

Study emphasizes benefits of newborn screening for CF patients

A new study led by a team from the Research Institute of the McGill University Health Centre and Cystic Fibrosis Canada reinforces the benefits of newborn screening for cystic fibrosis (CF) patients.

Winning by a nose: promising news for spinal cord injury patients

Cells from the human nose are showing further promise in remediating spinal cord injury, according to research from the University of New South Wales (UNSW).

Bone-marrow-derived MSCs can promote fracture healing

Mesenchymal stem cells (MSCs) have been transplanted to successfully treat a variety of diseases and conditions. The benefit of using MSCs is their ability to self-renew and differentiate into a variety of specialized cell types, such as osteoblasts (cells contributing to bone formation), chondrocytes (cartilage cells), adipocytes (fat cells), myocardiocytes (the muscle cells that make up the cardiac muscle), and neurons (nervous system cells).

Epilepsy drugs analyzed for causing increased risk of suicide in patients

While the Food and Drug Administration requires a warning of an increased risk of suicide for all epilepsy drugs, a new study shows that only certain drugs may increase the risk. The study is published in the July 27, 2010, issue of Neurology, the medical journal of the American Academy of Neurology. Newer drugs with a higher risk of causing depression than other epilepsy drugs, such as levetiracetam, topiramate and vigabatrin, were found to increase the risk of self-harm or suicidal behavior among people with epilepsy.

Althea extends labeling, packaging of biological product services through Sherpa

Althea Technologies, Inc. announced today that it has extended its service offering to include labeling, packaging, storage and distribution of drug and biological products through its co-marketing partner, Sherpa Clinical Packaging.

William A Christmas, DO - Emergency Medicine in Arcadia, MO